Silvia Finotto

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Blood · 2008 · 217 citations · Full text

Combination of Rituximab, Bendamustine, and Cytarabine for Patients With Mantle-Cell Non-Hodgkin Lymphoma Ineligible for Intensive Regimens or Autologous Transplantation

Carlo Visco, Silvia Finotto, Renato Zambello et al. · Journal of Clinical Oncology · 2013 · 171 citations · Full text

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

Carlo Visco, Annalisa Chiappella, Luca Nassi et al. · The Lancet Haematology · 2016 · 135 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +6

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia

Omar Perbellini, Erika Falisi, Ilaria Giaretta et al. · Haematologica · 2014 · 44 citations · Full text

B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities

Erika Falisi, Elisabetta Novella, Carlo Visco et al. · Hematological Oncology · 2013 · 35 citations

Mixed-phenotype Acute Leukemia, Immunology, Pathology +17